
Feature|Videos|November 19, 2025
Setting the Stage: The Boardroom Hot Seat
Author(s)David Edelman, Thrivable
This episode acts as a peek inside the modern pharma boardroom, where leaders are expected to defend billion-dollar brands with data that’s too slow, too vague, and too outdated to survive today’s market velocity.
Advertisement
This episode spotlights the escalating pressure inside the pharma boardroom. Markets are shifting overnight, competitors are moving at warp speed, and leaders are expected to explain performance with data that’s six weeks old and only tells half the story. Teams feel unprepared while the stakes have never been higher; from sudden GLP-1 coverage changes to compounding pharmacy disruptions, massive market swings can happen in a weekend. This is the new hot seat, and hesitation or guesswork can cost billions.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Industry’s Communication and Engagement with FDA
2
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
3
Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration
4
Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio
5





